Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Sees Significant Drop in Short Interest

Shionogi & Co., Ltd. (OTCMKTS:SGIOF) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 2,662,200 shares, a decrease of 13.1% from the February 13th total of 3,064,000 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 26,622.0 days.

Shionogi & Co., Ltd. Stock Performance

Shares of OTCMKTS:SGIOF remained flat at $13.45 during mid-day trading on Wednesday. 1 shares of the stock were exchanged, compared to its average volume of 260. Shionogi & Co., Ltd. has a 52 week low of $12.21 and a 52 week high of $16.53. The firm’s fifty day simple moving average is $13.93 and its two-hundred day simple moving average is $18.15.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.